On May 8, the U.S. Food and Drug Administration (FDA) approved the Senza spinal cord stimulation (SCS) system to help manage chronic intractable pain of the trunk and/or limbs. The system can reduce pain without paresthesia by providing high frequency stimulation (at 10 KHz) and low stimulation amplitudes. Read more.
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder